Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier)

Clinical trial NCT00575055 · COMPLETED

Trial details

NCT number: NCT00575055
Sponsor: JANSSEN Alzheimer Immunotherapy Research & Development, LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Alzheimer's Disease

Start date: 2007-12-01
Primary completion: 2012-04-01
Enrollment: 1121

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.